Skip to content
10-Q

Quarterly Report

Yew Bio-Pharm Group, Inc.

0001493152-20-021299

← back to feed
Filed
Nov 13, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2020 · Nov 12, 2020 51.7M sh
Shares Diluted Q3 2020 · Sep 30, 2020 51.7M sh
Shares Diluted Q3 2020 · Sep 30, 2020 51.7M sh
Shares Diluted Q3 2020 · Sep 30, 2019 51.7M sh
Shares Diluted Q3 2020 · Sep 30, 2019 51.78M sh
Short Term Debt Q3 2020 · Sep 30, 2020 $8.17M
Short Term Debt Q3 2020 · Dec 31, 2019 $8.54M
Cash And Equivalents Q3 2020 · Sep 30, 2020 $1.22M
Cash And Equivalents Q3 2020 · Dec 31, 2019 $742.29K
Stockholders Equity Q3 2020 · Sep 30, 2020 $44.06M
Stockholders Equity Q3 2020 · Dec 31, 2019 $41.39M
Stockholders Equity Q3 2020 · Sep 30, 2019 $42.05M
Stockholders Equity Q3 2020 · Dec 31, 2018 $41.09M
Current Liabilities Q3 2020 · Sep 30, 2020 $10.2M
Current Liabilities Q3 2020 · Dec 31, 2019 $10.48M
Total Liabilities Q3 2020 · Sep 30, 2020 $12.6M
Total Liabilities Q3 2020 · Dec 31, 2019 $12.81M
Current Assets Q3 2020 · Sep 30, 2020 $13.6M
Current Assets Q3 2020 · Dec 31, 2019 $11.67M
Total Assets Q3 2020 · Sep 30, 2020 $56.67M
Total Assets Q3 2020 · Dec 31, 2019 $54.21M
Eps Diluted Q3 2020 · Sep 30, 2020 $0.02
Eps Diluted Q3 2020 · Sep 30, 2020 $0.04
Eps Diluted Q3 2020 · Sep 30, 2019 $0.02
Eps Diluted Q3 2020 · Sep 30, 2019 $0.06
Eps Basic Q3 2020 · Sep 30, 2020 $0.02
Eps Basic Q3 2020 · Sep 30, 2020 $0.04
Eps Basic Q3 2020 · Sep 30, 2019 $0.02
Eps Basic Q3 2020 · Sep 30, 2019 $0.06
Capex Q3 2020 · Sep 30, 2019 $18.73K
Operating Cash Flow Q3 2020 · Sep 30, 2019 $11.54M
Sga Expense Q3 2020 · Sep 30, 2019 $391.81K
Sga Expense Q3 2020 · Sep 30, 2019 $905.22K
Net Income Q3 2020 · Sep 30, 2019 $1.18M
Net Income Q3 2020 · Sep 30, 2019 $3M
Operating Income Q3 2020 · Sep 30, 2019 $1.07M
Operating Income Q3 2020 · Sep 30, 2019 $2.75M
Gross Profit Q3 2020 · Sep 30, 2019 −$41.21K
Gross Profit Q3 2020 · Sep 30, 2019 $1.76M
Cost Of Revenue Q3 2020 · Sep 30, 2019 $708.73K
Cost Of Revenue Q3 2020 · Sep 30, 2019 $22.98M
Revenue Q3 2020 · Sep 30, 2019 $667.53K
Revenue Q3 2020 · Sep 30, 2019 $24.75M